Jiangsu BioPerfectus Technologies Co., Ltd. (hereinafter referred to as “BioPerfectus”) is pleased to announce that Monkeypox Virus Real Time PCR Kit has been approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) and is now officially available for Great Britain and Northern Ireland market.

With over 600 thousand new cases and more than half that would lead to death each year, cervical cancer is listed as the fourth most frequent cancer among women worldwide.

Sexually transmitted diseases (STDs), also known as sexually transmitted infections (STIs), are infections caused by organisms that can be transmitted from one person to another through sexual activity and intimate contact.

Bioperfectus is pleased to announce a strategic partnership with ELITechGroup S.p.A for monkeypox virus testing across Europe. The Monkeypox Virus Real Time PCR Kit from Bioperfectus in combination with the fully automated sample-to-result ELITe InGenius and BeGenius instruments from ELITechGroup will address the needs of major reference laboratories, hospitals, and disease control centers in Europe.

Bioperfectus, together with our partner in France, R-Biopharm France, has completed the clinical validation of the Bioperfectus Monkeypox Virus Real Time PCR Kit in l’institut de recherche biomédicale des armées (the Institute of Biomedical Research of the Armed Forces, IRBA), an organization established by the Army Health Service (SSA) in France.

Chlamydia is a common STD (Sexually Transmitted Disease) that can cause infection among men and women, leading to permanent damage to women’s reproductive system, making it difficult or impossible to get pregnant later.

Bioperfectus Human Papillomavirus Real Time PCR Kit & Human Papillomavirus Genotyping Real Time PCR Kit are free upgrading to meet different laboratories’ demands.

HFMD is a significant health and economic burden for the Asia Pacific region. It has been estimated that the average direct and indirect cost was US$129 for an outpatient, $484 for an inpatient, and $1936 for a severe case of HFMD, respectively.

WHO Director-General Tedros Adhanom Ghebreyesus Ph.D. said on 29 June 2022, COVID-19 cases are rising in 110 countries, driven by BA.4 and BA.5 in many places, causing overall global cases to increase by 20%, and deaths have risen in three of the six WHO regions.

Mr. TUNC MERT SAYIN addressed the opening ceremony of the Training Workshop on Monkeypox Diagnosis Using Real Time PCR Technique held by Africa Centers for Disease Control and Prevention in collaboration with Nigeria Center for Disease Control (Nigeria CDC) and Africa Society for Laboratory Medicine (ASLM).